0000000000018329

AUTHOR

Lukas Hobohm

showing 47 related works from this author

Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease

2021

Background: In patients with peripheral artery disease (PAD), the impact of diabetes mellitus (DM) on patient-profile and adverse in-hospital events is not well investigated. Methods: The German nationwide inpatient sample 2005–2019 was used for this analysis. Hospitalized PAD patients were stratified for DM and the influence of DM on patient-profile and adverse in-hospital events was investigated. Results: Our study comprised 2,654,871 hospitalizations (54.3% aged ≥70 years, 36.7% females) of patients with PAD in Germany 2005–2019. Among these, 864,691 (32.6%) patients had DM and 76,716 (2.9%) died during hospitalization. Diabetic PAD patients revealed an aggravated cardiovascular profile …

medicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentRGeneral MedicineDiseasemedicine.diseaseperipheral artery diseaseArticlemyocardial infarctionHospital outcomesAmputationInternal medicineDiabetes mellitusamputationdiabetes mellitusmedicinePatient profileMedicineMyocardial infarctionAdverse effectbusinessJournal of Clinical Medicine
researchProduct

In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism.

2020

AbstractAimsCatheter-directed treatment of acute pulmonary embolism (PE) is technically advancing. Recent guidelines acknowledge this treatment option for patients with overt or imminent haemodynamic decompensation, particularly when systemic thrombolysis is contraindicated. We investigated patients with PE who underwent catheter-directed thrombolysis (CDT) in the German nationwide inpatient cohort.Methods and resultsData from hospitalizations with PE (International Classification of Disease code I26) between 2005 and 2016 were collected by the Federal Office of Statistics in Germany. Patients with PE who underwent CDT (OPS 8-838.60 or OPS code 8-83b.j) were compared with patients receiving…

medicine.medical_specialtyCathetersTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineLower risk03 medical and health sciences0302 clinical medicineFibrinolytic AgentsInternal medicineMedicineHumansDecompensationThrombolytic Therapy030212 general & internal medicineProspective StudiesRetrospective Studiesbusiness.industryMortality rateGeneral MedicineOdds ratioThrombolysismedicine.diseaseHospitalsPulmonary embolismTreatment OutcomeCohortCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFibrinolytic agentEuropean heart journal. Acute cardiovascular care
researchProduct

Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients.

2020

Stroke is the second leading cause of death worldwide. Ischemic strokes, which are caused by atrial fibrillation/flutter (AF), may be more devastating than those that occur without AF.The purpose of this study was to investigate the impact of AF on adverse events in hospitalized ischemic stroke patients and to estimate the elevated impact of AF on the occurrence of these adverse events.The nationwide German inpatient sample of the years 2005-2015 was used for this analysis. Ischemic stroke patients were identified by ICD code I63 and stratified by AF. Logistic regression models were used to investigate the impact of AF on adverse in-hospital events and adjusted for age, sex, and comorbiditi…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyLogistic regressionBrain Ischemia03 medical and health sciences0302 clinical medicineRisk FactorsPhysiology (medical)Internal medicineCause of DeathGermanyCase fatality rateAtrial FibrillationmedicineHumanscardiovascular diseases030212 general & internal medicineHospital MortalityAdverse effectStrokeCause of deathAgedRetrospective StudiesAged 80 and overInpatientsAtrial fibrillation flutterbusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePrognosisSurvival RateAtrial FlutterIschemic strokeCardiologyFemaleCardiology and Cardiovascular MedicinebusinessHeart rhythm
researchProduct

Centre procedural volume and adverse in‐hospital outcomes in patients undergoing percutaneous transvenous edge‐to‐edge mitral valve repair usingMitra…

2021

AIMS The number of transcatheter mitral valve repair (TMVr) procedures has increased substantially during the last years. A better understanding of the relationship between hospital volume of transcatheter transvenous mitral valve repairs using MitraClip® and patient outcomes may provide information for future policy decisions to improve patient management. METHODS AND RESULTS We analysed patient characteristics and in-hospital outcomes for all TMVr procedures using MitraClip® performed in Germany from 2011 to 2017. Hospitals were stratified according to centre volumes and patients were compared for baseline characteristics and adverse in-hospital events. Overall, 24 709 inpatients were tre…

Cardiac Catheterizationmedicine.medical_specialtyPercutaneousmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineGermanyMitral valvemedicineHumansHeart FailureHeart Valve Prosthesis ImplantationMitral regurgitationMitral valve repairbusiness.industryMitraClipMitral Valve InsufficiencyOdds ratiomedicine.diseaseHospitalsConfidence intervalSurgeryPulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisMitral ValveCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure
researchProduct

Venous thromboembolism in patients hospitalized for hip joint replacement surgery

2020

Venous thromboembolism (VTE) is a potentially life-threatening disease. Major transient risk factors include trauma, surgery, and immobilization. Patients undergoing hip joint replacement (HJR) are characterized by a high risk of postoperative VTE, but data on the time trends of VTE rates in this population are sparse.In an analysis of the German nationwide inpatient sample, we included all hospitalizations for elective primary HJR in Germany from 2005 to 2016. Time trends of the surgical procedure, overall death rates, and VTE rates were analysed, and predictors of VTE identified.Overall, 1,885,839 inpatients with elective primary HJR (59.1% women, 51.4% ≥70 years) were included in the ana…

Malemedicine.medical_specialtyArthroplasty Replacement HipPopulation2720 Hematology610 Medicine & healthDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsHip replacementGermanymedicineHumanscardiovascular diseasesHospital Mortalityeducationeducation.field_of_studybusiness.industryMortality rate10031 Clinic for AngiologyCancerPerioperativeVenous ThromboembolismHematologyequipment and suppliesmedicine.diseaseSurgeryPulmonary embolismHospitalization030220 oncology & carcinogenesisFemalebusinessVenous thromboembolism
researchProduct

Survival Benefit of Obese Patients With Pulmonary Embolism.

2018

To investigate the impact of obesity and underweight on adverse in-hospital outcomes in pulmonary embolism (PE).Patients diagnosed as having PE based on International Statistical Classification of Diseases and Related Health Problems, 10th Revision, German Modification code I26 in the German nationwide inpatient database were stratified for obesity, underweight, and normal weight/overweight (reference group) and compared regarding adverse in-hospital outcomes.From January 1, 2011, through December 31, 2014, 345,831 inpatients (53.3% females) 18 years and older were included in this analysis; 8.6% were obese and 0.5% were underweight. Obese patients were younger (67.0 vs 73.0 years), were mo…

Malemedicine.medical_specialtymedicine.medical_treatmentEmbolectomyOverweightThinnessInterquartile rangeInternal medicinemedicineHumansHospital MortalityObesitySurvival rateAgedAged 80 and overbusiness.industryMortality rateGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismSurvival RateFemalemedicine.symptomUnderweightbusinessPulmonary EmbolismBody mass indexMayo Clinic proceedings
researchProduct

Definition of tachycardia for risk stratification of pulmonary embolism

2020

Tachycardia is a reliable predictor of adverse outcomes in normotensive patients with acute pulmonary embolism (PE). However, different prognostic relevant heart rate thresholds have been proposed. The aim of the study was to investigate the prognostic performance of different thresholds used for defining tachycardia in normotensive PE patients.We performed a post-hoc analysis of normotensive patients with confirmed PE consecutively included in a single-centre and a multi-centre registry. An adverse outcome was defined as PE-related death, need for mechanical ventilation, cardiopulmonary resuscitation or administration of catecholamines.Of 1567 patients (median age: 72 [IQR, 59-79] years; f…

Tachycardiamedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineTachycardiaInternal medicineHeart rateInternal MedicineHumansMedicineIn patient030212 general & internal medicineCardiopulmonary resuscitationAgedMechanical ventilationbusiness.industryGuidelineMiddle AgedPrognosismedicine.diseasePulmonary embolismROC CurveRisk stratificationCardiologyFemalemedicine.symptomPulmonary EmbolismbusinessEuropean Journal of Internal Medicine
researchProduct

Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany

2019

Seasonal variation regarding the incidence and the short-term mortality of acute myocardial infarction (MI) was frequently reported, but data about sex-specific differences are sparse.We analysed the impact of seasons and temperature on incidence and in-hospital mortality of patients with acute MI in Germany between 2005 and 2015.The nationwide sample comprised 3,008,188 hospitalizations of MI patients (2005-2015). The incidence was 334.7/100,000 citizens/year. Incidence inclined from 316.3 to 341.6/100,000 citizens/year (β 0.17 [0.10 to 0.24], P  0.001), while in-hospital mortality rate decreased from 14.1% to 11.3% (β -0.29 [-0.30 to -0.28], P  0.001). Overall, 377,028 (12.5%) patients di…

MaleMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesSex Factors0302 clinical medicineGermanymedicineHumansIn patientHospital Mortality030212 general & internal medicineMyocardial infarctionSex DistributionAcute miAgedRetrospective Studiesbusiness.industryIncidenceMortality rateIncidence (epidemiology)Seasonalitymedicine.diseaseSex specificHospitalizationSurvival RateSummer seasonFemaleSeasonsCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesForecastingDemographyInternational Journal of Cardiology
researchProduct

Sex-specific differences in pulmonary embolism

2019

Abstract Introduction Sex-specific differences regarding risk factors, symptoms and prognosis have been reported for several cardiovascular diseases. For patients with pulmonary embolism (PE), sex-specific data are limited and inconsistent. We aimed to investigate sex-specific differences in PE. Materials and methods Over a 10-year period (01/2003–09/2013), patients with confirmed PE were enrolled in a prospective single-centre cohort study. Results We prospectively examined 569 PE patients (55.9% women). Men more often had cancer (20.7% vs. 13.5%, p = 0.024) and unprovoked PE (61.0% vs. 47.5%, p = 0.001) while women more frequently presented with risk factors for venous thromboembolism suc…

MaleTachycardiamedicine.medical_specialty030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineProspective StudiesAgedSex Characteristicsbusiness.industryCancerHematologyMiddle AgedHypoxia (medical)medicine.diseaseSex specific3. Good healthPulmonary embolism030220 oncology & carcinogenesisRisk stratificationBiomarker (medicine)Femalemedicine.symptomPulmonary EmbolismbusinessCohort studyThrombosis Research
researchProduct

Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension

2019

Background Inflammation and incomplete thrombus resolution leading to obstructive fibrotic remodelling are considered critical mechanisms for the development of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary embolism (PE). Osteopontin (OPN) is involved in a variety of biological processes including inflammation and tissue fibrosis. Methods OPN plasma concentrations were measured in 70 CTEPH and 119 PE patients. Tissue material from 6 CTEPH patients removed during pulmonary endarterectomy and murine venous thrombi induced by subtotal ligation of the inferior vena cava in C57BL/6 mice were analysed by (immuno)histochemistry. Results CTEPH patients had higher OPN plasma…

Male0301 basic medicinePathologymedicine.medical_specialtyHypertension Pulmonarymedicine.medical_treatmentInflammationEndarterectomy030204 cardiovascular system & hematologyInferior vena cavaTranslational Research BiomedicalPathogenesisMice03 medical and health sciences0302 clinical medicinestomatognathic systemFibrosisThromboembolismmedicineAnimalsHumansProspective StudiesOsteopontinThrombusMyofibroblastsAgedEndarterectomyInflammationbiologybusiness.industryThrombosisHematologyMiddle AgedPrognosismedicine.diseaseFibrosisPulmonary embolismMice Inbred C57BL030104 developmental biologymedicine.veinChronic Diseasebiology.proteinFemaleOsteopontinmedicine.symptomPulmonary EmbolismbusinessBiomarkersThrombosis and Haemostasis
researchProduct

Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development

2017

Expanding evidence indicates multiple interactions between the hemostatic system and innate immunity, and the coagulation and complement cascades. Here we show in a tissue factor (TF)-dependent model of flow restriction-induced venous thrombosis that complement factors make distinct contributions to platelet activation and fibrin deposition. Complement factor 3 (C3) deficiency causes prolonged bleeding, reduced thrombus incidence, thrombus size, fibrin and platelet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro. Initial fibrin deposition at the vessel wall over 6 hours in this model was dependent on protein disulfide isomerase (PDI) and TF expressi…

0301 basic medicineComplement component 5biologyChemistryImmunologyCell BiologyHematologyComplement factor I030204 cardiovascular system & hematologymedicine.diseaseBiochemistryFibrinCell biologyComplement system03 medical and health sciences030104 developmental biology0302 clinical medicineCoagulationImmunologymedicinebiology.proteinPlateletPlatelet activationThrombusBlood
researchProduct

Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany

2020

Background Studies have reported seasonal variations regarding the incidence and the short-term mortality of pulmonary embolism (PE). The aim of this study was to identify sex-specific and age-related differences in seasonal patterns regarding hospitalisations and mortality of PE patients. Methods We analysed the impact of seasons on incidence and in-hospital mortality of male and female hospitalised PE patients in Germany (2005–2015) based on the German nationwide inpatient sample. Results The German nationwide inpatient sample comprised 885 806 hospitalisations due to PE (2005–2015). Seasonal variations of both incidence (p=0.021) and in-hospital mortality (p<0.001) were of significant ma…

Pulmonary and Respiratory MedicinePulmonary Vascular Disease7In hospital mortalitybusiness.industryIncidence (epidemiology)lcsh:Rlcsh:MedicineOriginal ArticlesSeasonalitymedicine.diseaseSex specificPulmonary embolismMale patientAge relatedFemale patientMedicinebusinessDemographyERJ Open Research
researchProduct

Impact of symptomatic atherosclerosis in patients with pulmonary embolism

2019

Atherosclerosis is associated with increased cardiovascular mortality. Associations between venous thromboembolism and atherosclerosis were recently reported. We aimed to investigate the impact of symptomatic atherosclerosis on adverse outcomes in patients with pulmonary embolism (PE) and to identify significant differences among patients with PE stratified by symptomatic atherosclerosis.Patients were selected by screening the nationwide inpatients sample for PE (ICD-code I26) stratified by symptomatic atherosclerosis (composite of coronary artery disease [ICD-code I25], myocardial infarction [ICD-code I21], ischemic stroke [ICD-code I63], and/or atherosclerotic arterial diseases [ICD-code …

Malemedicine.medical_specialtyDeep vein030204 cardiovascular system & hematologyThrombophlebitisCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctionThrombusAgedAged 80 and overbusiness.industryAge FactorsMiddle AgedAtherosclerosismedicine.diseaseThrombosisPulmonary embolismmedicine.anatomical_structureHeart failureCardiologyFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney Injury

2020

Background: Psoriasis is a chronic inflammatory disease which affects the body far beyond the skin. Whereas there is solid evidence that chronic skin inflammation in psoriasis drives cardiovascular disease, the impact on renal impairment and acute kidney injury (AKI) is still unclear. We aimed to analyze the impact of psoriasis on the in-hospital outcome of patients hospitalized with AKI. Methods: In this retrospective database study, we investigated data on characteristics, comorbidities, and in-hospital outcomes for all hospitalized patients with AKI stratified for concomitant psoriasis, which were collected by the Federal Office of Statistics in Germany between 2005 and 2016. Results: Am…

trendsmedicine.medical_specialtymedicine.medical_treatmentdermatoepidemiologylcsh:MedicineDisease030204 cardiovascular system & hematologyurologic and male genital diseasesArticle030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAKIInternal medicinePsoriasismedicineIn patientMyocardial infarctionStrokeDialysisbusiness.industrylcsh:RAcute kidney injuryGeneral Medicinepsoriasismedicine.diseasemortalityConcomitantbusinessJournal of Clinical Medicine
researchProduct

Comparison of risk assessment strategies for not-high-risk pulmonary embolism

2015

We compared the prognostic performance of the 2014 European Society of Cardiology (ESC) risk stratification algorithm with the previous 2008 ESC algorithm, the Bova score and the modified FAST score (based on a positive heart-type fatty acid-binding protein (H-FABP) test, syncope and tachycardia, modified using high-sensitivity troponin T instead of H-FABP) in 388 normotensive pulmonary embolism patients included in a single-centre cohort study.Overall, 25 patients (6.4%) had an adverse 30-day outcome. Regardless of the score or algorithm used, the rate of an adverse outcome was highest in the intermediate-high-risk classes, while all patients classified as low-risk had a favourable outcome…

MalePulmonary and Respiratory MedicineTachycardiamedicine.medical_specialty030204 cardiovascular system & hematologyFatty Acid-Binding ProteinsRisk AssessmentSyncope03 medical and health sciences0302 clinical medicineRisk FactorsTachycardiaInternal medicineOdds RatiomedicineHumansProspective StudiesProspective cohort studyAgedTroponin Tbusiness.industryArea under the curveOdds ratioMiddle AgedPrognosismedicine.disease3. Good healthPulmonary embolismROC Curve030228 respiratory systemCohortCardiologyRegression AnalysisFemalemedicine.symptomPulmonary EmbolismbusinessRisk assessmentFatty Acid Binding Protein 3AlgorithmsEuropean Respiratory Journal
researchProduct

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

2018

Management and outcome of patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) who underwent pulmonary endarterectomy (PEA) at a large German referral center were investigated.In Germany, 394 PEAs were performed in 2014 and 2015 with an in-hospital mortality rate of 5.8%. Of these, 253 patients (64.2%) were treated at the Kerckhoff Clinic, Bad Nauheim, and 237 (93.7%; median age, 62 years [interquartile range [IQR], 52-72 years]; 46.0% female) were included in the present analysis.On referral, 52 patients (22.0%) were treated with pulmonary arterial hypertension-specific drugs and 95 (40.4%) were treated with non-vitamin K-dependent oral anticoagulants, and 14 (5.9%)…

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtyReferralbusiness.industryMortality rate030204 cardiovascular system & hematologySurgeryPulmonary endarterectomy03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangemedicine.arteryPulmonary arteryMedicineReferral centerSurgeryChronic thromboembolic pulmonary hypertensionCardiology and Cardiovascular MedicinebusinessThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
researchProduct

Impact of Atrial Fibrillation on Postoperative Adverse Outcomes of Surgical Patients With Knee Endoprosthetic Surgery

2018

Atrial fibrillation/flutter (AF) is associated with increased mortality, thromboembolism, heart failure, and adverse perioperative outcomes. We aimed to investigate the impact of AF on adverse in-hospital outcomes of hospitalized patients who underwent knee endoprosthetic surgery (KES).The nationwide German inpatient sample of the years 2005-2015 was used for this analysis. Patients who underwent KES were identified based on the surgical and interventional procedural codes (surgery and procedure code [Operationen-und Prozedurenschlüssel] 5-822), and patients were further stratified by AF (International Classification of Diseases and Related Health Problems code I48). We compared patients wi…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsCause of DeathGermanyThromboembolismAtrial FibrillationOdds RatiomedicineHumansOrthopedics and Sports MedicineHospital MortalityPostoperative Period030212 general & internal medicineMyocardial infarctionArthroplasty Replacement KneeStrokeAgedHeart FailureInpatientsbusiness.industryAtrial fibrillationPerioperativeLength of StayMiddle Agedmedicine.diseaseArthroplastyPulmonary embolismSurgeryStrokeLogistic ModelsRelative riskHeart failureFemalebusinessThe Journal of Arthroplasty
researchProduct

Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism

2021

Abstract Background Venous thromboembolism (VTE) is common and associated with high morbidity and mortality. Although chronic inflammation was not categorized as a traditional risk factor for VTE, chronic inflammation might increase the risk to develop VTE events. While studies confirmed an increased cardiovascular morbidity and mortality in psoriatic patients, data regarding the influence of psoriasis on patients' cardiovascular profile and on prognosis of patients with pulmonary embolism (PE) are sparse. Purpose We aimed to investigate the impact of psoriasis on prognosis of PE patients. Methods Hospitalized PE patients were stratified for psoriasis and the impact of psoriasis on outcome …

Malemedicine.medical_specialtyYounger agebusiness.industryVenous Thromboembolismmedicine.diseasePulmonary embolismVenous thrombosisIncreased riskRisk FactorsInternal medicinePsoriasismedicineHumansPsoriasisFemaleHospital MortalityPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessVenous thromboembolismAgedEuropean Heart Journal
researchProduct

Clinical impact of diabetes mellitus in patients hospitalized for myocardial infarction

2020

Abstract Background Diabetes mellitus (DM) represents a major cardiovascular risk factor for coronary artery disease and myocardial infarction (MI). Purpose We aimed to assess in-hospital events and time trends in MI patients with and without DM between 2005 and 2016 in Germany. Methods The nationwide German inpatient sample 2005–2016 was used for statistical analysis (source: Research Data Center (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states, DRG Statistics 2005–2016, own calculations). Hospitalized MI patients were stratified for the presence of DM and the impact of DM on in-hospital events was investigated. Results A total of 3,307,703 patients…

medicine.medical_specialtybusiness.industryAtrial fibrillationmedicine.diseaseComorbidityObesityThrombosisPneumoniaInternal medicineDiabetes mellitusmedicineMyocardial infarctionCardiology and Cardiovascular MedicineHemostatic functionbusinessEuropean Heart Journal
researchProduct

Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.

2019

Abstract Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death; systemic thrombolysis is potentially lifesaving treatment in patients presenting with haemodynamic instability. We investigated trends in the use of systemic thrombolysis and the outcome of patients with acute PE. Methods and results We analysed data on the characteristics, comorbidities, treatment, and in-hospital outcome of 885 806 PE patients in Germany between 2005 and 2015. Incidence of acute PE was 99/100 000 population/year and increased from 85/100 000 in 2005 to 109/100 000 in 2015 [β 0.32 (0.26–0.38), P &amp;lt; 0.001]. During the same period, in-hospital case fatality rates decreased fro…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsInternal medicineGermanyCase fatality ratemedicineHumansThrombolytic TherapyCardiopulmonary resuscitationHospital MortalityeducationCause of deathAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryMortality rate030229 sport sciencesThrombolysisMiddle Agedmedicine.diseasePulmonary embolismTreatment OutcomeAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFibrinolytic agentFollow-Up StudiesEuropean heart journal
researchProduct

Syncope in the German Nationwide inpatient sample – Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by hig…

2019

Syncope is a common phenomenon in the general population. Although most of the causes are of benign origin, some comorbidities are accompanied by high mortality. We aimed to compare the in-hospital mortality of patients with syncope related to different comorbities and investigate the impact of syncope in patients with atrial fibrillation/flutter (AF).The nationwide inpatient sample of Germany of the years 2011-2014 was used for this analysis. Patients with syncope (ICD-code R55) were stratified by presence of selected comorbidities. Additionally, AF patients with and without syncope were compared. Incidence of syncope and in-hospital mortality were calculated. Syncope as a predictor of adv…

AdultMalemedicine.medical_specialtyPopulationMyocardial InfarctionComorbidity030204 cardiovascular system & hematologySyncopeYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathGermanyInternal medicineAtrial FibrillationInternal MedicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctioneducationStrokeAgedAged 80 and overHeart Failureeducation.field_of_studybiologybusiness.industryIncidenceMortality rateIncidence (epidemiology)Syncope (genus)Atrial fibrillationPneumoniaMiddle Agedmedicine.diseasebiology.organism_classificationPulmonary embolismStrokeLogistic ModelsMultivariate AnalysisCardiologyFemalePulmonary EmbolismbusinessEuropean Journal of Internal Medicine
researchProduct

Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease.

2019

Peripheral artery disease (PAD) and chronic obstructive pulmonary disease (COPD) are both related with high in-hospital mortality. We aimed to investigate the impact of COPD on the in-hospital outcomes in PAD.PAD patients were selected based on ICD-code I70.2 of the German nationwide database, stratified for COPD and compared regarding adverse in-hospital outcomes.Between 01/2005-12/2015, 5,611,827 inpatients (64.8% males) were diagnosed with PAD; of those, 13.6% were coded additionally with COPD. Overall, 277,894 PAD patients (5.0%) died during in-hospital course. Prevalence of cardiovascular diseases as well as cancer (12.1% vs. 7.0%, P  0.001) was higher in PAD patients with COPD compare…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyArterial diseasemedicine.medical_treatmentMyocardial InfarctionPulmonary diseaseDiseaseIndependent predictorAmputation Surgical03 medical and health sciencesPeripheral Arterial DiseasePulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineNeoplasmsmedicinePrevalenceHumans030212 general & internal medicineHospital MortalityAgedAged 80 and overCOPDbusiness.industryNationwide databaseCancerMiddle Agedmedicine.diseaserespiratory tract diseases030228 respiratory systemAmputationCardiovascular DiseasesFemalebusinessPulmonary EmbolismRespiratory medicine
researchProduct

5-Year Experience of In-Hospital Outcomes After Percutaneous Left Atrial Appendage Closure in Germany

2019

The aim of this study was to evaluate 5-year in-hospital trends and safety outcomes of left atrial appendage (LAA) closure in the German nationwide inpatient sample.The safety and efficacy of percutaneous LAA closure have been demonstrated in randomized trials and prospective cohort studies, but results from large samples are missing.Data on patient characteristics and in-hospital safety outcomes for all percutaneous LAA closures performed in Germany between 2011 and 2015 were analyzed. Overall, 15,895 inpatients were included.The annual number of LAA occlusions increased from 1,347 in 2011 to 4,932 in 2015 (β = 1.00; 95% confidence interval [CI]: 0.95 to 1.01; p 0.001), with a nonsignifica…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsPercutaneousHealth StatusComorbidity030204 cardiovascular system & hematologyPericardial effusionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawCause of DeathGermanyAtrial FibrillationHumansMedicineAtrial AppendageHospital Mortality030212 general & internal medicineProspective cohort studyStrokeAgedAged 80 and overbusiness.industryMortality rateAtrial fibrillationmedicine.diseaseConfidence intervalSurgeryTreatment OutcomeAtrial Function LeftFemaleCardiology and Cardiovascular MedicinebusinessJACC: Cardiovascular Interventions
researchProduct

Defining right ventricular dysfunction by the use of echocardiography in normotensive patients with pulmonary embolism

2020

Although the prognostic value of various echocardiographic parameters of right ventricular dysfunction (RVD) was reported in normotensive patients with acute pulmonary embolism (PE), there is no generally accepted definition of RVD.The aim of the study was to compare echocardiographic parameters for the prediction of an adverse 30‑day outcome and create an optimal definition of RVD.                                     Patients and methods: Echocardiographic parameters including the right ventricular to left ventricular diameter ratio (RV to LV ratio) and tricuspid annular plane systolic excursion (TAPSE) to predict PE‑related mortality, hemodynamic collapse, or rescue thrombolysis within th…

medicine.medical_specialtyVentricular Dysfunction Rightmedicine.medical_treatmentHemodynamicsBlood Pressure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHumansMedicineProspective Studies030212 general & internal medicineReceiver operating characteristicbusiness.industryArea under the curveThrombolysismedicine.diseaseRight ventricular dysfunction3. Good healthPulmonary embolismBlood pressureIncreased riskEchocardiographyCardiologyPulmonary EmbolismbusinessPolish Archives of Internal Medicine
researchProduct

Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolis…

2020

Pulmonary embolism is the third most frequent acute cardiovascular disease with an annual incidence of approximately 100 cases per 100 000 population and an annual mortality of ≥7 deaths per 100 000 population in the European region [1, 2]. Initial management is adjusted to the risk of in-hospital death or early complications, which depend both on the severity of pulmonary embolism and the presence of comorbidities [3]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors hav…

RiskPulmonary and Respiratory Medicinemedicine.medical_specialtyDownloadPopulationMEDLINESubgroup analysisGerman03 medical and health sciences0302 clinical medicineHealth careAmbulatory CaremedicineHumans030212 general & internal medicineeducationeducation.field_of_studybusiness.industryConflict of interestlanguage.human_language030228 respiratory systemMultinational corporationFamily medicinelanguagePulmonary EmbolismbusinessEuropean Respiratory Journal
researchProduct

In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism

2020

Abstract Background and purpose Catheter-directed treatment of acute pulmonary embolism (PE) is technically advancing. Recent guidelines acknowledge this treatment option for patients with overt or imminent haemodynamic decompensation, particularly when systemic thrombolysis is contraindicated or has failed. We investigated baseline characteristics and in-hospital outcomes of patients with PE who underwent catheter-directed thrombolysis (CDT) in the German nationwide inpatient cohort. Methods Data from hospitalizations with PE between 2005 and 2016 were collected by the Federal Office of Statistics (Statistisches Bundesamt) in Germany and included in this analysis. Patients with PE who unde…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMortality rateThrombolysisOdds ratiomedicine.diseaseLower riskPulmonary embolismInternal medicineCohortmedicineDecompensationCardiology and Cardiovascular MedicinebusinessFibrinolytic agentEuropean Heart Journal
researchProduct

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014

2016

Infective endocarditis (IE) is a potentially life-threatening disease. Little is known about temporal trends in its prevalence in Germany. In 2009, recommendations for antibiotic prophylaxis were deescalated in the revised European Society of Cardiology guideline to include only patients at high risk of IE. We selected patients with the discharge diagnosis of IE based on the International Classification of Diseases code I33 in the nationwide database of the Federal Statistical Office of Germany. We identified 94,364 patients with a diagnosis of IE from January 2005 to December 2014. Mean prevalence was 11.6 per 100,000 citizens per year in this 10-year-period. The annual IE prevalence showe…

Pediatricsmedicine.medical_specialtyEndocarditisbusiness.industryNationwide databaseGuidelineDisease030204 cardiovascular system & hematologymedicine.diseaseConfidence intervalHospitalization03 medical and health sciences0302 clinical medicineGermanyInfective endocarditisCase fatality ratePrevalenceHumansMedicineEndocarditis030212 general & internal medicineAntibiotic prophylaxisCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Impact of pulmonary embolism on in-hospital mortality of patients with ischemic stroke

2020

Pulmonary embolism (PE) is a frequent complication in immobile stroke patients and an important cause of death in stroke patients. We aimed to investigate predictors of PE and the impact of PE on survival of ischemic stroke patients.Patients were selected by screening the German nationwide inpatient sample (2005-2017) for ischemic stroke (ICD-code I63) and stratified for occurrence of PE (ICD-code I26). Impact of PE on mortality and predictors for PE in ischemic stroke patients were analysed.Overall, 2,914,546 patients were hospitalized due to ischemic stroke (50.5% females; 69.3% aged ≥70 years) in Germany 2005-2017. Among these, 0.4% had PE and 7.2% died during hospitalization. In-hospita…

MaleResuscitationmedicine.medical_specialtymedicine.medical_treatmentBrain Ischemia03 medical and health sciences0302 clinical medicineGermanyInternal medicineHumansMedicineHospital Mortalitycardiovascular diseases030212 general & internal medicineAgedIschemic StrokeCause of deathIn hospital mortalitybusiness.industryMortality rateThrombolysismedicine.diseasePulmonary embolismStrokeNeurologyIschemic strokeCardiologyFemaleNeurology (clinical)Pulmonary EmbolismbusinessComplication030217 neurology & neurosurgeryJournal of the Neurological Sciences
researchProduct

Venous thromboembolism in patients hospitalized for knee and hip joint replacement surgery

2020

Abstract Background Venous thromboembolism (VTE) is a frequent acute cardiovascular disease, leading to significant morbidity and mortality worldwide. Major trauma, surgery, immobilisation and joint replacements are major provoking factors for VTE. In particular, patients undergoing knee and hip joint replacement surgery are at high risk of developing VTE perioperatively, even in the era of established pharmacological thromboprophylaxis. Without thromboprophylaxis, as many as 20–60% of patients may develop perioperative VTE. Purpose As recent studies indicate an increasing number of total knee and hip replacement surgeries in European countries and the United States, aims of our study were …

medicine.medical_specialtybusiness.industrymedicineIn patientCardiology and Cardiovascular MedicinebusinessVenous thromboembolismHip joint replacementSurgeryEuropean Heart Journal
researchProduct

Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction

2020

Diabetes mellitus (DM) represents a major cardiovascular risk factor for increased risk of coronary artery disease and myocardial infarction (MI). DM is also associated with a poorer clinical outcome in MI.The nationwide German inpatient population treated between 2005 and 2016 was used for statistical analyses. Hospitalized MI patients were stratified by the presence of DM and investigated for the impact of DM on in-hospital events.In total, 3,307,703 hospitalizations for acute MI (37.6% female patients, 56.8% aged ≥ 70 years) treated in Germany during 2005-2016 were included in this analysis. Of these patients, 410,737 (12.4%) died while in hospital. Overall, 1,007,326 (30.5%) MI cases we…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMyocardial Infarction030209 endocrinology & metabolism030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineDiabetes MellitusInternal MedicinemedicineHumansHospital MortalityMyocardial infarctionRisk factoreducationAgededucation.field_of_studybusiness.industryMortality rateMetabolic disorderGeneral Medicinemedicine.diseaseTreatment OutcomeIncreased riskFemalebusinessDiabetes &amp; Metabolism
researchProduct

Impact of atrial fibrillation/flutter on the in-hospital mortality of surgical patients – Results from the German nationwide cohort

2020

To investigate the impact of atrial fibrillation/flutter (AF) on adverse in-hospital outcomes in hospitalized surgical patients.The nationwide German inpatient sample of the years 2005-2018 was used for this analysis. Surgical patients were stratified by AF and compared. Logistic regression models were used to investigate the impact of AF on in-hospital outcomes.In total, 96,589,627 hospitalizations with surgery were included in the present analysis in Germany (2005-2018). Among these, 6,680,261 were additionally coded with AF (6.9%). In-hospital death rate was substantially higher in surgical patients with AF (6.3%) than without (1.1%). Proportion of surgical patients with AF increased fro…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyLogistic regression03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationmedicineHumansHospital MortalityRisk factorHeart FailureAtrial fibrillation flutterIn hospital mortalitybusiness.industryMortality rateAtrial fibrillationHematologymedicine.diseaseAtrial Flutter030220 oncology & carcinogenesisCohortFemalebusinessSurgical patientsThrombosis Research
researchProduct

Predictors of short‐ and long‐term outcomes of patients undergoing transcatheter mitral valve edge‐to‐edge repair

2020

Objectives Transcatheter mitral valve repair (TMVR) by edge-to-edge therapy is an established treatment for severe mitral valve regurgitation (MR). Background Symptomatic and prognostic benefit in functional MR has been shown recently; nevertheless, data on long-term outcomes are sparse. Methods and results We analyzed survival of patients treated with isolated edge-to-edge repair from June 2010 to March 2018 (primarily combined edge-to-edge repair with other mitral valve interventions was excluded) in a retrospective monocentric study. Overall, 627 consecutive patients (47.0% females, 78.6 years in mean) were included. Leading etiology was functional MR (57.4%). Follow-up regarding surviva…

MaleCardiac Catheterizationmedicine.medical_specialtymedicine.medical_treatmentDischarged alive030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineMitral valveLong term outcomesmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineRetrospective StudiesHeart Valve Prosthesis ImplantationCOPDMitral valve repairMitral regurgitationbusiness.industryMitral Valve InsufficiencyGeneral Medicinemedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structureEtiologyMitral ValveFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessCatheterization and Cardiovascular Interventions
researchProduct

Home treatment of fragile patients with acute pulmonary embolism: a subgroup analysis of the multinational home treatment of pulmonary embolism (HoT-…

2020

Abstract Background and aims Subgroup analyses of randomized trials and cohort studies on direct oral anticoagulants (DOACs) suggested that single direct drug treatment may be effective and safe in elderly and “fragile” patients with acute pulmonary embolism (PE). In a post-hoc analysis of HoT-PE, a prospective multicenter management trial, we studied whether early discharge and home treatment of acute PE is effective and safe in these patients. Methods HoT-PE enrolled patients with acute PE classified as being at low risk based on the modified Hestia criteria and the absence of right ventricular dysfunction. The primary efficacy outcome was symptomatic recurrent VTE, or PE-related death wi…

medicine.medical_specialtybusiness.industryAbsolute risk reductionRenal functionSubgroup analysismedicine.diseasePulmonary embolismPharmacotherapyInternal medicineCardiologyMedicineHome treatmentCardiology and Cardiovascular MedicinebusinessVenous thromboembolismEuropean Heart Journal
researchProduct

Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany.

2020

Abstract Aims We investigated trends in incidence, case fatality rate, patient characteristics and adverse inhospital events of patients hospitalised for heart failure in Germany. Methods and results The German nationwide inpatient sample (2005–2016) was used for this analysis. Patients hospitalised due to heart failure were selected for analysis. Temporal trends in the incidence of hospitalisations, case fatality rate and treatments were analysed and predictors of inhospital death were identified. The analysis comprised a total number of 4,539,140 hospitalisations (52.0% women, 81.0% aged ≥70 years) due to heart failure. Although hospitalisations increased from 381 (2005) to 539 per 100,00…

Heart transplantationHeart FailureMalemedicine.medical_specialtyEpidemiologybusiness.industryIncidence (epidemiology)medicine.medical_treatmentPatient characteristicsComorbiditymedicine.diseaseHospitalizationHeart failureGermanyCase fatality rateEmergency medicineMedicineHumansIn patientFemaleHospital MortalityCardiology and Cardiovascular MedicinebusinessAgedEuropean journal of preventive cardiology
researchProduct

Impact of Systemic Atherosclerosis on Clinical Characteristics and Short-Term Outcomes in Patients with Deep Venous Thrombosis or Thrombophlebitis

2020

Venous thromboembolism (VTE) and atherosclerosis are accompanied by substantial cardiovascular mortality; links between both disease entities were reported. We aimed to investigate the impact of systemic atherosclerosis on adverse outcomes in patients with deep venous thrombosis or thrombophlebitis (DVT) and to identify differences in DVT patients with and without systemic atherosclerosis.The German nationwide inpatient sample was used for this analysis. Patients admitted for DVT were included in this study and stratified by systemic atherosclerosis (composite of coronary artery disease, myocardial infarction, ischemic stroke, and/or atherosclerotic arterial diseases). We compared DVT patie…

Malemedicine.medical_specialtyDiseaseThrombophlebitisCoronary artery diseaseRisk FactorsInternal medicinemedicineHumanscardiovascular diseasesMyocardial infarctionVenous Thrombosisbusiness.industryVenous ThromboembolismGeneral MedicineThrombophlebitisAtherosclerosismedicine.diseasePulmonary embolismVenous thrombosisConcomitantHeart failureCardiologyFemalePulmonary EmbolismbusinessThe American Journal of the Medical Sciences
researchProduct

Risk factors for chronic thromboembolic pulmonary hypertension – Importance of thyroid disease and function

2019

Abstract Introduction Although a number of risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) have been reported, the exact prevalence is controversial and varies between published cohorts. The aim of the present study was to investigate the prevalence of risk factors in operable CTEPH patients with special emphasis on thyroid disease and function. Material and methods Overall, 228 CTEPH patients (47.7% female; median age 63 [IQR 52–72] years) scheduled for pulmonary endarterectomy between 01/2014 and 12/2015 were studied. Prevalence of risk factors was assessed, and patients were classified according to their thyroid function based on laboratory measurements. Results As…

Malemedicine.medical_specialtyendocrine system diseasesHypertension PulmonaryLevothyroxineCardiac index030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansEuthyroidRisk factorAgedbusiness.industryThyroid diseaseHematologyMiddle Agedmedicine.diseaseThyroid DiseasesPulmonary embolism030220 oncology & carcinogenesisChronic DiseaseFemaleChronic thromboembolic pulmonary hypertensionThyroid functionPulmonary Embolismbusinessmedicine.drugThrombosis Research
researchProduct

COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report

2021

AbstractImmune thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder characterized by severely reduced activity of the von Willebrand factor (VWF)-cleaving protease ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) due to autoantibodies. This leads to the development of pathogenic multimers of VWF, causing a thrombotic microangiopathy with decreased number of platelets, hemolysis, and life-threatening tissue ischemia of mostly brain, heart, and kidneys. Standard treatment of iTTP involves daily plasma exchange to remove ultra large multimers of VWF, inhibitors, substituting ADAMTS13, and the accompaniment of an immunosuppressive …

Thrombotic microangiopathybiologybusiness.industryThrombotic thrombocytopenic purpuraAutoantibodyHematology030204 cardiovascular system & hematologymedicine.diseaseADAMTS1303 medical and health sciences0302 clinical medicineVon Willebrand factorhemic and lymphatic diseases030220 oncology & carcinogenesisImmunologybiology.proteinmedicineRituximabPlateletCaplacizumabbusinessmedicine.drugHämostaseologie
researchProduct

Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism

2021

Venous thromboembolism (VTE) constitute a major global burden of disease. Current international guidelines recommend treatment with anticoagulant therapy after VTE for a duration of at least 3 months. Since anticoagulation also imposes an increased risk for bleeding events, the individual risk has to be evaluated to determine adequate treatment plans.The nationwide German inpatient sample of the years 2005-2017 was used for this analysis. Hospitalized VTE patients were stratified according to Kuijer risk class and the performance of the Kuijer score was evaluated to predict adverse in-hospital events.Overall, 1,204,895 VTE patients were treated between 2005 and 2017 in Germany and were incl…

medicine.medical_specialtyHemorrhage030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeGermanyInternal medicinemedicineHumansIn patientHospital Mortality030212 general & internal medicinebusiness.industryAnticoagulantsVenous ThromboembolismOdds ratiomedicine.diseaseHospitalsConfidence intervalPulmonary embolismVenous thrombosisCardiology and Cardiovascular MedicinebusinessVenous thromboembolismInternational Journal of Cardiology
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2) : a multinational, multicentre, single-ar…

2021

BACKGROUND: Current guidelines recommend a risk-adjusted treatment strategy for the management of acute pulmonary embolism. This is a particular patient category for whom optimal treatment (anticoagulant treatment, reperfusion strategies, and duration of hospitalisation) is currently unknown. We investigated whether treatment of acute intermediate-risk pulmonary embolism with parenteral anticoagulation for a short period of 72 h, followed by a switch to a direct oral anticoagulant (dabigatran), is effective and safe. METHODS: We did a multinational, multicentre, single-arm, phase 4 trial at 42 hospitals in Austria, Belgium, France, Germany, Italy, Netherlands, Romania, Slovenia, and Spain. …

Malemedicine.medical_specialtyPopulationAdministration OralHemorrhage030204 cardiovascular system & hematologyDrug Administration ScheduleDabigatran03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumans030212 general & internal medicineeducationAgedAged 80 and overeducation.field_of_studyRIGHT-VENTRICULAR DYSFUNCTION VENOUS THROMBOEMBOLISM DABIGATRAN MANAGEMENT WARFARIN HOSPITALIZATION RATIONALE HEPARIN DESIGNHeparinbusiness.industryAnticoagulantsVenous ThromboembolismHematologyGuidelineHeparinMiddle AgedInterim analysismedicine.diseaseThrombosisDabigatran3. Good healthPulmonary embolismClinical trialTreatment OutcomeFemalePulmonary EmbolismbusinessFollow-Up Studiesmedicine.drug
researchProduct

Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy …

2019

Infective endocarditis (IE) is a potentially life-threatening disease. Regardless the improvements in IE management, it remains associated with high mortality and severe complications. Staphylococci and streptococci account for 80% of all IE cases. Prevention of IE by appropriate administration of antibiotics before procedures with potential bacteremia in selected patients is recommended according to recent and current guidelines. However, recent studies, have questioned the efficacy of antimicrobial prophylaxis in special situations and in some patient-groups. As a consequence, the guideline of the French working group on IE in 2002, the American Heart Association (AHA) guideline in 2007, …

medicine.medical_specialtyMEDLINENiceDisease030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicinemedicineHumans030212 general & internal medicineAntibiotic prophylaxisIntensive care medicinecomputer.programming_languageEndocarditisbusiness.industryIncidenceIncidence (epidemiology)GuidelineAntibiotic Prophylaxismedicine.diseaseUnited StatesEuropeInfective endocarditisBacteremiaGuideline AdherenceCardiology and Cardiovascular MedicinebusinesscomputerMinerva Cardioangiologica
researchProduct

Risk Factors for Pulmonary Embolism in Patients with Paralysis and Deep Venous Thrombosis

2021

Background. Venous thromboembolism is a frequent complication and an important cause of death in patients with paralysis. We aimed to investigate predictors of pulmonary embolism (PE) and the impact of PE on the survival of patients with paralysis in comparison to those with deep venous thrombosis or thrombophlebitis (DVT). Methods: Patients were selected by screening the German nationwide inpatient sample (2005–2017) for paralysis, and were stratified for venous thromboembolism (VTE) and the VTE-sub-entity PE (ICD-code I26). Impact of PE on mortality and predictors for PE were analyzed. Results: Overall, 7,873,769 hospitalizations of patients with paralysis were recorded in Germany 2005–20…

medicine.medical_specialtyCOPDpulmonary embolismbusiness.industryRGeneral Medicineparalysismedicine.diseaseThrombophlebitisstrokemortalityArticlespinal cord injuryPulmonary embolismVenous thrombosisInternal medicineHeart failureParalysismedicineMedicinecardiovascular diseasesmedicine.symptombusinessStrokeCause of deathJournal of Clinical Medicine
researchProduct

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

2018

To externally validate the prognostic impact of copeptin, either alone or integrated in risk stratification models, in pulmonary embolism (PE), we performed a post hoc analysis of 843 normotensive PE patients prospectively included in three European cohorts.Within the first 30 days, 21 patients (2.5%, 95% CI 1.5–3.8) had an adverse outcome and 12 (1.4%, 95% CI 0.7–2.5) died due to PE. Patients with copeptin ≥24 pmol·L−1 had a 6.3-fold increased risk for an adverse outcome (95% CI 2.6–15.5, p&lt;0.001) and a 7.6-fold increased risk for PE-related death (95% CI 2.3–25.6, p=0.001). Risk classification according to the 2014 European Society of Cardiology (ESC) guideline algorithm identified 248…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyValidation studyAdverse outcomes030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineCopeptinRisk groupsRisk FactorsInternal medicinePost-hoc analysismedicineHumansProspective StudiesAgedAged 80 and overbusiness.industryGlycopeptidesMiddle Agedmedicine.diseasePrognosisPulmonary embolismIncreased riskLogistic Models030228 respiratory systemROC CurveRisk stratificationFemalebusinessPulmonary EmbolismAlgorithmsBiomarkersThe European respiratory journal
researchProduct

Impact of concomitant deep or superficial venous thrombosis of the legs on survival of patients with pulmonary embolism

2019

Pulmonary embolism (PE) is a frequent cause of death and morbidity. A few studies suggest that clot burden in pulmonary artery bed is related to PE patients' survival, but the impact of concomitant deep venous thrombosis and/or thrombophlebitis (DVT) on short-term survival of PE patients remains unclear. Thus, we aimed to investigate the impact of DVT on adverse outcomes in PE patients.Patients of the nationwide inpatient sample with PE (ICD-code I26) were stratified for DVT (ICD-code I80) and compared for patient characteristics, risk stratification markers, treatments and outcomes. Impact of concomitant DVT on adverse in-hospital outcomes was tested.Overall, 346,586 PE patients (53.3% fem…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicine.arterymedicineHumanscardiovascular diseases030212 general & internal medicineCause of deathVenous ThrombosisInpatientsLegbusiness.industryCancermedicine.diseasePulmonary embolismVenous thrombosisConcomitantPulmonary arterySuperficial venous thrombosisFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Obesity paradox in peripheral artery disease

2019

Background & aims: Previous studies have suggested an obesity survival paradox in patients with peripheral artery disease (PAD). We investigated the influence of obesity and underweight on adverse in-hospital outcomes in PAD. Methods: Patients diagnosed with PAD based on ICD-code I70.2 of the German nationwide database were stratified for obesity, underweight and a reference group with normal-weight/over-weight and compared regarding adverse in-hospital outcomes. Results: Between 01/2005-12/2015, 5,611,484 inpatients (64.8% males) were diagnosed with PAD; of those, 8.9% were coded with obesity and 0.3% with underweight. Obese patients were younger (70 (IQR 63/76) vs. 73 (66/80) years, P < 0…

Male0301 basic medicinemedicine.medical_specialtyArterial diseasemedicine.medical_treatment030209 endocrinology & metabolismDiseaseCritical Care and Intensive Care MedicineCohort StudiesPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineThinnessGermanyInternal medicineHumansMedicineHospital MortalityObesityAged030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryCancerMiddle Agedmedicine.diseaseObesityAmputationFemaleUnderweightmedicine.symptombusinessLower mortalityObesity paradoxClinical Nutrition
researchProduct

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - R…

2019

Background and aim: The number of percutaneous edge-to-edge mitral regurgitation (MR) valve repairs with MitraClip® implantations increased exponentially in recent years. Studies have suggested an obesity survival paradox in patients with cardiovascular diseases. We investigated the influence of obesity on adverse in-hospital outcomes in patients with MitraClip® implantation. Methods and results: We analyzed data on characteristics of patients and in-hospital outcomes for all percutaneous mitral valve repairs using the edge-to-edge MitraClip®-technique in Germany 2011–2015 stratified for obesity vs. normal-weight/over-weight. The nationwide inpatient sample comprised 13,563 inpatients under…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsDatabases FactualEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyProsthesis DesignRisk Assessment03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsGermanyInternal medicineMitral valvemedicineHumansHospital MortalityObesityAgedAged 80 and overHeart Valve Prosthesis ImplantationMechanical ventilationMitral regurgitationNutrition and Dieteticsbusiness.industryMitraClipMitral Valve Insufficiencymedicine.diseasePulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessObesity paradoxNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Identification of normotensive patients with pulmonary embolism who may benefit from thrombolysis.

2019

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentThrombolysismedicine.diseasePulmonary embolismFibrinolytic AgentsInternal medicinemedicineCardiologyHumansIdentification (biology)Thrombolytic TherapyCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismInternational journal of cardiology
researchProduct